Michael Marash Israeli cancer treatment co P-Cure raises $15m

P-Cure CEO: "Completion of the financing round will enable us to make the smart medical solution we have developed accessible to any oncological center that offers radiotherapy.

Medical devices Photo: Shutterstock ASAP Creative Embolic protection device co Filterlex raises $3m

The Israeli company has developed the CAPTIS device for reducing the risk of stroke and other complications during catheter-based structural heart procedures.

Israel Biotech Fund Photo: PR Israel Biotech Fund reports first closure of 2nd fund

The volume and extent of the closure was not disclosed, but is probably similar to IBF's first fund, which raised $70 million.

antibacterial fabric Sheets that combat bugs, clothes that stay soft

Sonovia is applying technology from Bar-Ilan University to make hospitals safer, and the fashion industry greener.

Elah Alkalay, Narkis Tessler and Barak Landes / Photo: Ravit Levran "Cannabis may affect women differently from men"

Nextar CEO Orna Dreazen told the Women's Health Innovations and Inventions Congress in Tel Aviv that more needs to be known about the impact of cannabis on women.

Kare Schultz Photo: Shlomi Yosef Morgan Stanley slashes Teva price target

US investment bank Morgan Stanley has downgraded Teva to "Underperform", citing renewed pressure on generics prices.

Healthcare Medical device co Inmode seeks $75m in Nasdaq IPO

Inmode had sales of $100 million last year of its aesthetic and medical treatment devices, and is profitable.

Check Cap Photo: Company website Check-Cap reports positive results on colon screening pill

The primary efficacy endpoint of the study was the ability of C-Scan to correctly identify patients with polyps and the patients without polyps.

Kare Schultz Photo: Shlomi Yosef IBI sees over 60% upside in Teva

IBI Investment House pharma analyst Steven Tepper thinks that the legal risks threatening Teva are being overpriced.

Teva Photo: Sivan Faraj Teva slumps as Trump turns attention to generic drug prices

The US president has ordered his staff to prepare an order lowering prescription drug prices in the US.

Mori Arkin Photo: Jonathan Bloom Sol-Gel jumps after reporting successful Phase 3 trial

The trial for Sol-Gel's Epsolay for treating rosacea achieved all its endpoints.

Zvi Marom  photo: Eyal Izhar BATM relists on the TASE

The company's market cap is more than double what it was when it was delisted.

Ori Yehudai Investors angry that Yehudai abandoned Sade

Some investors have filed a lawsuit following Ori Yehudai's abrupt resignation as chairman of the cannabis company.

Ori Yehudai  photo: Eyal Izhar Ori Yehudai quits cannabis co Sade after two months

Yehudai, who built Frutarom into a company sold for $7.1 billion, is stepping down as executive chairman of Sadé Group.

Eyal and Giora Davidovits  photo: PR A blood test that detects cancer early

Israeli company Savicell's product doesn't look for cancer cells, but for tell-tale immune system reactions.

Richard Carleton  photo: PR The Canadian stock exchange high on cannabis

Canadian Securities Exchange CEO Richard Carleton: Israel is a strong cannabis brand.

Ariella Golomb Photo: PR InnovaHealth seeks Israeli medical device investments

InnovaHealth cofounder Dr. Ariella Golomb talks about the sale of OrthoSpace and says the fund seeks late stage investments in orthopedic and women's health companies.

Dr. Ron Lahav, Dr. Osnat Ohne, Dr. Sharon Fireman  photo: Dani Machlis Biotech's valley of death ends in Beersheva

The National Institute for Biotechnology takes an innovative approach to commercializing Ben Gurion University of the Negev's groundbreaking research.

Sagi Menuhin, Ido Ramot, Ilan Tsinman, Eli Bar-on  photo: Cadit Levy The company magnifying the effect of cannabis

Entou Labs has developed a product that it says improves absorption of cannabis, cutting dosage, side effects, and cost.

Kare Schultz Photo: Shlomi Yosef Little chance of Teva CEO seeing share price bonus

Kare Schultz received millions of dollars of blocked shares, which he will receive if the share price reaches a certain level by November 2020.

Prof. Shulamit Levenberg Photo: Rami Chelouche Israeli researcher offers hope in overcoming paralysis

By implanting engineered tissue from stem cells taken from the gums, the Technion's Prof. Shulamit Levenberg provides new hope for people with spinal column injuries.

Prof. Irad Ben-Gal  photo: Eyal Izhar The times they are a-changing us

Prof. Irad Ben-Gal talks to "Globes" about dual digital and physical existence, and other ways technology will challenge our present assumptions about human life.

Dr. Anda Baharav Photo: Shlomi Yosef Sleeprate's app and cognitive therapy end insomnia

At 55, Dr. Anda Baharav left her work as a pediatrician to found a startup that provides personalized treatment for sleep disorders.

Prof. Tal Dvir Photo: Eyal Izhar "Barriers are more regulatory than technological"

Having 3D printed a heart, Tel Aviv University's Prof. Tal Dvir says in principle, he can regenerate any organ in the body.

Tel Aviv traffic jam  photo: Eyal Izhar The new government's economic challenges

Transport, energy and healthcare are three areas where big decisions loom, and determination will be needed to carry them out.

Cannabis plant Photo: Shutterstock Israel's cannabis reform: Hopes and fears

"Globes" examines what the pioneering medical cannabis reform, due to come into effect after the election, will mean for patients, doctors, and all concerned.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018